Therefore, to confirm the roles of these genes on the vital regulatory mechanisms in breast cancer, we compared the potential role of novel RGs (SF1, TRA2B, THRAP3, RHOA, and QRICH1) vs. traditional RGs (ACTB, and GAPDH) in the normalization of target gene expression. This evidence concerns the gene GAPDH and breast carcinoma.